Материал: Маркелова Е.В. Персистирующие вирусные инфекции. этиология и иммунопатогенез

204.Hill, T. J. Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection / T.J. Hill, D.A. Harbour, W.A. Blyth // Gen. Virol. – 1980. – V. 47, №1. – Р. 205–207.

205.Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICPO-mediated de-repression / H.M. Coleman, V. Connor, Z.S. Cheng et al. // J. Gen Virol. – 2008. – V. 89, №1. – P. 68–77.

206.Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity / M. Moraru, E. Cisneros, N. Gomez-Lozano et al. // J. Immunol. – 2012. – V. 188, №9. – P. 4412–4420.

207.ВПГ immune complex (ВПГ-IgG: IC) and ВПГ-DNA elicit the production of angiogenic factor VEGF and MMP-9 / K. Hayashi, L. C. Hooper, B. Detrick, J.J. Hooks // Arch Virol. – 2009. – V. 154, №2. – P. 219–226.

208.Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis / A. Arvin, G. Campadelli-Fiume, E. Mocarski et al. – Cambridge: Cambridge University Press, 2007. – Bookshelf ID: NBK 47378.

209.Immune control of herpes simplex virus during latency / K.M. Khanna, A.J. Lepisto, V. Decman, R.L. Hendricks // Curr. Opin. Immunol. – 2004. – V. 16, №4. – P. 463–469.

210.Immunity to ocular and genital herpes simplex viruses infections / A.A. Chentoufi, L. BenMohamed, P. Van De Perre, A.A. Ashkar // Clinical and Developmental Immunology. – V. 2012. – Article ID 732546, 2 P. doi: 10.1155 / 2012 / 732546.

211.Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses / K.J. Laing, L. Dong, J. Sidney et al. // Clinic. Exper. Immunol. – 2011. – V. 167, №1. – P. 47–58.

212.Impairment in reactivation of a latency associated transcript (LAT)-deficient ВПГ-2 is not solely dependent on the latent viral load or the number of CD8+ T cells infiltrating the ganglia / Y. Hoshino, L. Pesnicak, S.E. Straus, J.I. Cohen // Virology. – 2009. – V. 387. – P. 193–199.

213.Intranasal immunization in mice with non-ionic surfactants vesicles containing ВПГ immunogens: a preliminary study as possible vaccine against genital herpes / R. Cortesi, L. Ravani, F. Rinaldi et al. // International Jounal of Phamaceutics. – 2012. – V. 44092. – P. 229–237.

214.Ito, M. Changes in intracellular cytokine levels in newborn and adult lymphocytes induced by ВПГ-1 / M. Ito, W. Koide, M. Sakurai // J. Med. Virol. – 1998. – V. 56, №2. – P. 145–150.

215.Jurak, I. Mammalian Alphaherpesvirus miRNAs / I. Jurak, A. Griffiths, D.M. Coen // Biochim. Biophys. Acta. – 2011. – V.1809, №11–12. – P. 641–653.

216.Koelle, D.M. Herpes simplex virus: the importance of asymptomatic shedding / D. M. Koelle, A. Wald // Antimicrob. Chemother. – 2000. – V. 45, S. T.3. – P. 1–8.

217.Koelle, D.M. Herpes simplex: insights on pathogenesis and possible vac-cineas / D.M. Koelle, L. Corey // Ann. ReV.Med. – 2008. – V. 59. – P. 382–395.

218.Lavrov, V.F. Natural immunity and herpes infection / V.F. Lavrov, L.V.Kov8alchuk, L.V.Gankovskaia // Vopr. Virusol. – 2006. – V. 51, №3. – P. 4–9.

219.Loss of mandibular lymph node integrity is associated with an increase in sensitivity to ВПГ-1 infection in CD118-deficient mice / C.D. Conrady, M. Thapa, T. Wuest, D.J. Carr // J. Immunol. – 2009. – V. 182, №6. – P. 3678–3687.

220.Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women / J. Mysliwska, P. Trzonkowski, E. Bryl et al. // Eur. Cytokine Netw. – 2000. – V. 11, №3. – P. 397–406.

221.Mansour, N. Facial herpes zoster infection precipitated by surgical manipulation of the trigeminal nerve during exploration of the posterior

fossa: a case report / N. Mansour, С. Kaliaperutal, К.А. Choudhari //

J.Medical Case Reports. – 2009. – V. 16, №3. – P. 7813.

222.Markert , J.M. Preclinical evaluation of a genetically engineered herpes sim-plex virus expressing lnterleukin-12 / J.M. Markert, J.J. Cody, J.N. Parker // J. Virol. – 2012. – V. 86, №9. – P. 5304–5315.

223.Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions / S.P. Deshpande, M. Zheng, S. Lee, B. T. Rouse // Vet. Microbiol. – 2002. – V. 86, №1–2. – P. 17–26.

224.Melchjorsen, J. Sensing herpes: more than toll / J. Melchjorsen // ReV.Med. Virol. – 2012. – V. 22. – P. 106–121.

225.Membrane reguirement for the folding of the ВПГ-1 gB cytodomain suggests a unigue mechanism of fusion regulation / J.L. Silverman, N.G. Greene, D.S. King, E.E. Heldwein // J. Virol. – 2012. – V. 86, №15. – P. 8171–8174.

226.Mendy, А. Seropositivity to herpes simplex virus type 2, but not type

1is associated with premature cardiovascular diseases: a population-based cross-sectional study / A. Mendy, E.R.Vieira, J. Gasana // Atherosclerosis. – 2013. – V. 231. – Issue 1. – P. 18–21.

227.Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs / G. Marks, N. Crepaz, J. Walton Senterfit et al. //

J.Arq. Immune Defic. Syndr. – 2005. – V. 39. – P. 446–453.

228.MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs / J.L. Umbach, M.F. Kramer, I. Jurak et al. // Nature. – 2008. – V. 454 (7205). – P.780–783.

229.Mikloska, Z. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission / Z. Mikloska, A.L. Cuiminghain // J. Virol. – 2001. – V. 75, №23. – P. 11821– 11826.

230.Miller, C.S. Molecular aspects of herpes simplex virus – I – latency, reactivation, and recurrence / C.S. Miller, R.J. Danaher, R.J. Jacob // Crit. ReV.Oral Biol. Med. – 1998. – V. 9, №4. – P. 541–562.

231.Mori, I. Herpes simplex virus US3 protein kinase regulates host responses and determines neurovirulence / I. Mori // Microbiol. Immunol. – 2012. – V. 56, №6. – P. 351–355.

232.Mundle, S.T. High-purity preparation of ВПГ-2 vaccine candidate

ACAM529 is immunogenic and efficacious in vivo / S.T. Mundle,

H.Hernandez, J. Hamberger et al. // PLOS ONE. – 2013. – V. 8. – e57224.

233.Murray, P.R. Medical Microbiology / P.R. Murray, K.S. Rosenthal, M.A. Pfaller. – 5th. – Elsevier Mosby, 2005. – ISBN 978–0–323–03303–9; ISBN 0–323–03303.

234.Naumann, M. Safety of botulinum toxin type A: a systematic review and meta-analysis / M. Naumann, J. Jankovic // Curr. Med. Res. Opin. – 2004. – V. 20, №7. – P. 981–990.

235.Netea, M.G. Immunodeficiency and genetic defects of patternrecognition receptors / M.G. Netea, J.W. van der Meer // N. Engl. J. Med. – 2011. – V. 364, №1. – P. 60–70.

236.Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of ВПГ-1 in BALB / c mice / M. Zheng, M.A. Fields, Y. Liu et al. // Invest. Ophthalmol. Vis. Sci. – 2008. – V. 49, №9. – P. 4018–4025.

237.Nicoll, M.P. The molecular basis of herpes simplex virus latency / M.P. Nicoll, J.T. Proenca, S. Efstathiou // FEMS Microbiol Rev. – 2012. – V. 36, №3. – Р. 684–705.

238.Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2 / I. Jurak, M. F. Kramer, J.C. Mellor et al. // J. Virol. – 2010. – V. 84, №9. – P. 4659–4672.

239.Paladino, P. Mechanisms employed by ВПГ-1 to inhibit the interferon re-sponse / P. Paladino, K.L. Mossman // J. Interferon and Cytokine Research. – 2009. – V. 29, №9. – P. 599–607.

240.Pan,M.Predictionandidentificationofpotentialimmunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2 /

M. Pan, X. Wang, J. Liao et al. // Clinical and Developmental Immunology. – V. – 2012. – Article ID 205313. – 8 p. 

241.Protection provided by a herpes simplex virus 2 (ВПГ-2) glycoprotein C and D subunit antigen vaccine against genital ВПГ-2 infection in ВПГ-1-seropositive guinea pigs / S. Awasthi, J.W. Balliet, J.A. Flynn et al. // American society for microbiology Journal of virology. – 2014. – V. 88, №4. – P. 2000–2010.

242.Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections / M.L. Freeman, B.S. Sheridan, R.H.Bonneau,R.L.Hendricks//Immunol. –2007. –V. 179,№1. –P. 322–328.

243.Recalcitrance of bacterial vaginosis among herpes-simplex-virus- type-2-seropositive women / K.A. Stoner, S.D. Reighard, R.D. Vicetti Miguel et al. // J. Obstet. Gynaecol. Res. – V. 38, №1. – P. 77–83.

244.Recognition of herpesviruses by the innate immune system / S.R. Paludan, A.G. Bowie, K.A. Horan, K.A. Fitzgerald // Nat. ReV. Immunol. – 2011. – V. 11, №2. – P. 143–154.

245.Reevaluating the CD8 T-cell response to herpes simplex virus type 1: in-volvement of CD8 T cells reactive to subdominant epitopes / B.S. Sheridan, T.X. Cherpes, J. Urban et al. // J. Virol. – 2009. – V. 83, №5. – P. 2237–2245.

246.Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection / H.L. Donaghy, L. Bosnjak,

A.M. Harman et al. // J. Virol. – 2009. – V. 83, №4. – P. 1952–1961.

247.Sato, A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells / A. Sato, M.M. Linehan, A. Iwasaki // Proc. Natl. Acad. Sci. USA. – 2006. – V. 10, №46. – P. 17343–17348.

248.Schiffer, J. T. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes / J.T. Schiffer, L. Abu-Raddad, K.E. Mark et al. // Proc. Natl. Acad. Sci. – 2010. – V. 107 – Р. 18973–8.

249.Schiffer, J.T. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection / J.T. Schiffer, L. Corey // Nat. Med. – 2013. – V. 19(3). – Р. 280–290.

250.Sgaier, S.K. Prevalence and correlates of Herpes Simplex Virus-2 and syphilis infections in the general population in India / S.K. Sgaier, P. Mony, S. Jayakumar et al. // Sex. Transm. Infect. – 2011. – V. 87. – Р. 94– 100.

251.Shin H. A vaccine strategy protects against genital herpes by establishing local memory T cells / H. Shin, A. Iwasaki // J. Nature. – 2012. –

V. 491, № 7424. – P. 463–467.

252.Spear, P.G. Herpes simplex virus: receptors and ligands for cell entry / P.G. Spear // Cell Microbiol. – 2004. – V. 6, №5. – P. 401–410.

253.STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection / A. Svensson, P. Tunbäck,I.Nordströmetal.//J.Virol. –2012. –V. 86,№17. –P. 9409–9415.

254.The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells /

A.A. Chentoufi, X. Dervillezi, G. Dasgupta et al. // Viral. Immunology. – 2012. – V. 25, №2. – P. 1–2.

255.The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B / A. Cartier, E. Broberg, T. Komai et al. // Cell Death Differ. – 2003. – V. 10, №12. – P. 1320–1328.

256.The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1 / S.J. Allen, P. Hamrah, D. Gate et al. // J. Virol. – 2011. – V. 85. – P. 4184–4197.

257.Thompson, R.L. Therapeutic implications of new insights into the critical role of VP 16 in initiating the earliest stages of ВПГ reactivation from latency / R.L. Thompson, N.M. Sawtell // Future Med. Chem. – 2010. –

V. 2, №7. – P. 1099–1105.

258.The multipartite system that mediates entry of herpes simplex virus into the cell / G. Campadelli-Fiume, M. Amasio, E. Avitabile et al. // ReV.Med. Virol. – 2007. – V. 17, №5. – P. 313–326.

259.TLR3 deficiency in patients with herpes simplex encephalitis / S.Y. Zhang, E. Jouanguy, S. Ugolini et al. // Science. – 2007. – V. 317, №5844. –

Р.1522–1527.

260.Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta / J. Wang, W. Zeng, P. Hu et al. // J. Cancer Cell International. – 2014. – V. 14, №1. – P. 83–92.

261.Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis / W. Shen, M. Sae Silva, T. Jaber et al. // J. Virol. – 2009. – V. 83, №18. – P. 9131–9139.

262.Understanding ВПГ-1 entry glycoproteins / A. Reske, G. Pollara, C. Kummenacher et al. // ReV.Med. Virol. – 2007. – V.17, №3. – P. 205–215.

263.Vessel wall enhancement in herpes simplex virus central nervous system vasculitis / W.R. Guerrero, H. Dababneh , S. Hedna , et al. // Journal of Clinical Neuroscience. – 2013. –V.20. – Issue 9. – P. 1318–1319.

264.Viral and cellular contributions to herpes simplex virus entry into the cell / G. Campadelli-Fiume, L. Menotti, E. Avitabile, T. Gianni // Current Opinion in Virology. – 2012. – V. 2, №1. – P. 28–36.